{"id":11566,"date":"2023-02-27T13:04:13","date_gmt":"2023-02-27T12:04:13","guid":{"rendered":"https:\/\/ggba.swiss\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/"},"modified":"2023-07-04T13:44:14","modified_gmt":"2023-07-04T11:44:14","slug":"terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/","title":{"rendered":"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer"},"content":{"rendered":"\n<p><a href=\"https:\/\/terapet.ch\/\" target=\"_blank\" rel=\"noopener\">Terapet<\/a> est une start-up du CERN qui travaille \u00e0 l&rsquo;am\u00e9lioration d&rsquo;une protonth\u00e9rapie r\u00e9volutionnaire pour le traitement du cancer. La protonth\u00e9rapie de la start-up bas\u00e9e \u00e0 Gen\u00e8ve est une forme avanc\u00e9e de radioth\u00e9rapie pour le traitement du cancer qui peut cibler les tumeurs avec une tr\u00e8s grande pr\u00e9cision, sans endommager les cellules saines proches de la tumeur. La nouvelle technologie de Terapet a le potentiel de rendre l&rsquo;imagerie de m\u00e9decine nucl\u00e9aire plus accessible \u00e0 tous les patients \u00e0 l&rsquo;avenir.<\/p>\n<p>Qual\u03b3scan, le premier produit de la soci\u00e9t\u00e9, est un nouveau dispositif d&rsquo;assurance qualit\u00e9 en protonth\u00e9rapie qui permettra d&rsquo;\u00e9valuer pour la premi\u00e8re fois la distribution de la dose en temps r\u00e9el. L&rsquo;appareil sera valid\u00e9 avec des partenaires cliniques de l&rsquo;Institut Karolinska et de la clinique Skandion. Dans les ann\u00e9es \u00e0 venir, la m\u00eame technologie permettra aux m\u00e9decins de surveiller la dose d\u00e9livr\u00e9e aux patients pendant le traitement du cancer in-vivo, de mani\u00e8re non invasive, en 3D et en temps r\u00e9el.<\/p>\n<p>Le Dr Christina Vallgren, CEO de Terapet, a d\u00e9clar\u00e9 : \u00ab\u00a0Avec notre solution, nous allons \u00e9liminer l&rsquo;un des plus grands obstacles \u00e0 la th\u00e9rapie par particules : s&rsquo;assurer que chaque patient re\u00e7oit la bonne dose, \u00e0 chaque fois. Nous sommes impatients de pr\u00e9senter notre premier produit \u00e0 la communaut\u00e9 de la th\u00e9rapie par particules lors du PTCOG de cette ann\u00e9e \u00e0 Madrid. Ce financement est essentiel pour soutenir la campagne de marketing et de vente de Qual\u03b3scan.\u00a0\u00bb<\/p>\n<p>Le tour de table a \u00e9t\u00e9 men\u00e9 conjointement par <a href=\"https:\/\/lakegenevaventures.com\/\" target=\"_blank\" rel=\"noopener\">EFI Lake Geneva Ventures<\/a> et <a href=\"https:\/\/www.nina.capital\/\" target=\"_blank\" rel=\"noopener\">Nina Capital<\/a>, avec le soutien de tous les actionnaires existants, y compris la <a href=\"https:\/\/www.fongit.ch\/fr\" target=\"_blank\" rel=\"noopener\">Fongit<\/a>, <a href=\"https:\/\/www.venturekick.ch\/fr\" target=\"_blank\" rel=\"noopener\">Venturekick<\/a>, et les fondateurs. Terapet accueille \u00e9galement Giovanni Leo d&rsquo;EFI Lake Geneva Ventures et Sebastian Anastassiou de Nina Capital au sein de son conseil d&rsquo;administration.<\/p>\n<p>\u00ab\u00a0Je suis ravi de rejoindre le conseil d&rsquo;administration de Terapet et de contribuer au d\u00e9veloppement de la prochaine g\u00e9n\u00e9ration de produits d&rsquo;imagerie nucl\u00e9aire. En tant que professionnel des technologies m\u00e9dicales, je suis depuis longtemps passionn\u00e9 par le potentiel de l&rsquo;imagerie m\u00e9dicale pour am\u00e9liorer les r\u00e9sultats des patients et je pense que Terapet est particuli\u00e8rement bien plac\u00e9e pour ouvrir la voie dans ce domaine. Je suis impatient de travailler aux c\u00f4t\u00e9s de l&rsquo;\u00e9quipe talentueuse de Terapet pour promouvoir l&rsquo;innovation, am\u00e9liorer notre technologie et, \u00e0 terme, avoir un impact significatif sur l&rsquo;industrie des soins de sant\u00e9\u00a0\u00bb, a expliqu\u00e9 Giovanni Leo, partenaire chez EFI Lake Geneva Ventures.<\/p>\n<p>Sebastian Anastassiou, directeur de Nina Capital et nouveau membre du conseil d&rsquo;administration, a indiqu\u00e9 : \u00ab\u00a0Je suis ravi de continuer \u00e0 soutenir Terapet dans la r\u00e9alisation de sa vision, qui consiste \u00e0 am\u00e9liorer radicalement les r\u00e9sultats pour les patients en d\u00e9veloppant l&rsquo;avenir de l&rsquo;imagerie nucl\u00e9aire. Avec des bases technologiques solides issues du <a href=\"https:\/\/www.home.cern\/fr\" target=\"_blank\" rel=\"noopener\">CERN<\/a> et une \u00e9quipe exceptionnelle, nous avons tous les ingr\u00e9dients n\u00e9cessaires pour travailler ensemble \u00e0 un v\u00e9ritable impact sur les soins de sant\u00e9.\u00a0\u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 medtech genevoise Terapet a annonc\u00e9 la cl\u00f4ture de son premier tour de table de pr\u00e9-s\u00e9rie A pour un montant de CHF 2,3 millions.<\/p>\n","protected":false},"author":3,"featured_media":11567,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1041,1094,1060,1065,1068],"class_list":["post-11566","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr","tag-medical-devices-2","tag-medtech-fr","tag-oncology-fr","tag-personalized-medicine-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 medtech genevoise Terapet a annonc\u00e9 la cl\u00f4ture de son premier tour de table de pr\u00e9-s\u00e9rie A pour un montant de CHF 2,3 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-27T12:04:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer\",\"datePublished\":\"2023-02-27T12:04:13+00:00\",\"dateModified\":\"2023-07-04T11:44:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\"},\"wordCount\":536,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg\",\"keywords\":[\"Financing\",\"Medical Devices\",\"Medtech\",\"Oncology\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\",\"name\":\"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg\",\"datePublished\":\"2023-02-27T12:04:13+00:00\",\"dateModified\":\"2023-07-04T11:44:14+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/","og_locale":"fr_FR","og_type":"article","og_title":"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer - Greater Geneva Bern area","og_description":"La soci\u00e9t\u00e9 medtech genevoise Terapet a annonc\u00e9 la cl\u00f4ture de son premier tour de table de pr\u00e9-s\u00e9rie A pour un montant de CHF 2,3 millions.","og_url":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-02-27T12:04:13+00:00","article_modified_time":"2023-07-04T11:44:14+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer","datePublished":"2023-02-27T12:04:13+00:00","dateModified":"2023-07-04T11:44:14+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/"},"wordCount":536,"image":{"@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg","keywords":["Financing","Medical Devices","Medtech","Oncology","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/","url":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/","name":"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg","datePublished":"2023-02-27T12:04:13+00:00","dateModified":"2023-07-04T11:44:14+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Terapet-Qualyscan-630x380-1-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/terapet-leve-chf-23-millions-pour-sa-technologie-innovante-de-traitement-du-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Terapet l\u00e8ve CHF 2,3 millions pour sa technologie innovante de traitement du cancer"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11566"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11566\/revisions"}],"predecessor-version":[{"id":18328,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11566\/revisions\/18328"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11567"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}